Hip Replacement Market Size, Share and Growth Outlook, 2026

Hip Replacement Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Hip Replacement Market size is forecast to increase from $5.48 Billion in 2026 to $7.16 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

The Hip Replacement market report provides detailed analysis and outlook of Hip Replacement segments including By Procedure Type (Total Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, Hip Resurfacing), By Material (Metal-on-Polyethylene (MoP), Ceramic-on-Polyethylene (CoP), Ceramic-on-Ceramic (CoC), Ceramic-on-Metal (CoM), Metal-on-Metal (MoM)), By Fixation Type (Cemented Fixation, Cementless Fixation, Hybrid Fixation), By End-User (Hospitals, Orthopedic Centers, Ambulatory Surgical Centers (ASCs)) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Hip Replacement Industry Overview

Technological Advancements Driving Modern Hip Arthroplasty

The hip replacement industry continues to evolve through significant advancements in surgical technology, implant design, biomaterials, and patient-specific treatment planning. Rising demand for total hip arthroplasty among aging populations and increasingly active younger patients is encouraging manufacturers to develop solutions that improve implant longevity, surgical precision, and post-operative outcomes. Orthopedic companies are investing heavily in robotic-assisted surgery platforms, advanced bearing materials, and innovative implant surface technologies to address complications such as implant wear, instability, and infection. These developments are helping transform hip replacement procedures into increasingly precise and durable interventions across global healthcare systems.

Robotic-Assisted Surgery Enhancing Implant Accuracy

Robotic-assisted technologies are becoming a central component of modern hip replacement procedures. Major orthopedic manufacturers have expanded deployment of robotic-assisted total hip arthroplasty platforms that combine advanced preoperative planning software with real-time intraoperative navigation capabilities. These integrated systems allow surgeons to optimize implant positioning, improve alignment accuracy, and personalize procedures according to individual patient anatomy. Stryker has further strengthened this trend through the expansion of its Trident II Acetabular System, which is specifically designed for compatibility with the Mako SmartRobotics platform. The integration of robotic guidance and advanced implant systems is helping improve procedural consistency and long-term joint performance.

Advanced Biomaterials Improving Implant Longevity

Material innovation remains a major driver of progress within the hip replacement industry. Recent clinical studies have reinforced the durability of highly cross-linked polyethylene and ceramic-on-ceramic bearing surfaces, particularly among younger and more physically active patients undergoing total hip replacement. These materials are designed to reduce wear rates and improve long-term implant survivorship compared to traditional bearing combinations. Stryker’s Trident II Acetabular System incorporates proprietary Tritanium In-Growth Technology alongside X3 highly cross-linked polyethylene liners to strengthen fixation and improve wear resistance. Such advancements are supporting the industry's focus on extending implant lifespan and reducing the likelihood of revision procedures.

Novel Implant Designs Addressing Infection and Instability Challenges

Manufacturers are increasingly developing specialized implant technologies to address persistent clinical complications. Zimmer Biomet achieved a significant milestone with the first total hip replacement utilizing an iodine-treated implant system in Japan. The iTaperloc Complete and iG7 Acetabular Hip Systems incorporate controlled-release iodine surface treatment designed to prevent biofilm formation and reduce the risk of periprosthetic joint infection. Meanwhile, Hip Innovation Technology received compassionate use authorization from the U.S. Food and Drug Administration for its Reverse Hip Replacement System. Unlike conventional hip replacement designs, the Reverse HRS reverses the traditional ball-and-socket configuration to enhance mechanical stability and reduce dislocation risk, particularly among patients with severe spinopelvic instability. These innovations highlight the industry's continued emphasis on improving patient outcomes through advanced implant engineering and targeted clinical solutions.

Hip Replacement Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Hip Replacement market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zimmer Biomet Holdings, Inc., DePuy Synthes (Johnson & Johnson), Stryker Corporation, Smith & Nephew plc, Corin Group PLC, Waldemar Link GmbH & Co. KG, MicroPort Scientific Corporation, Exactech, Inc., Corentec Co., Ltd., Enovis Corporation. The Hip Replacement market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Hip Replacement industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Hip Replacement Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Hip Replacement companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Hip Replacement markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Hip Replacement Market Competitive Benchmarking and Company Analysis

Leading companies in Hip Replacement industry include- Zimmer Biomet Holdings, Inc., DePuy Synthes (Johnson & Johnson), Stryker Corporation, Smith & Nephew plc, Corin Group PLC, Waldemar Link GmbH & Co. KG, MicroPort Scientific Corporation, Exactech, Inc., Corentec Co., Ltd., Enovis Corporation. The Hip Replacement market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Hip Replacement Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Hip Replacement market remains one of the strongest-performing segments in the country.
The US Hip Replacement Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Hip Replacement market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Hip Replacement industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Hip Replacement markets

Canada's strong Hip Replacement sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Hip Replacement market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Hip Replacement Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Hip Replacement market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Hip Replacement population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Hip Replacement industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Hip Replacement market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Hip Replacement sales through 2034

France Hip Replacement companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Hip Replacement Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Hip Replacement distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Hip Replacement Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Hip Replacement market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Hip Replacement industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Hip Replacement industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Hip Replacement Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Hip Replacement market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Hip Replacement market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Hip Replacement Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Hip Replacement Market Segmentation

By Procedure Type
Total Hip Replacement
Partial Hip Replacement
Revision Hip Replacement
Hip Resurfacing
By Material
Metal-on-Polyethylene (MoP)
Ceramic-on-Polyethylene (CoP)
Ceramic-on-Ceramic (CoC)
Ceramic-on-Metal (CoM)
Metal-on-Metal (MoM)
By Fixation Type
Cemented Fixation
Cementless Fixation
Hybrid Fixation
By End-User
Hospitals
Orthopedic Centers
Ambulatory Surgical Centers (ASCs)

Top Companies in Hip Replacement Industry

Zimmer Biomet Holdings, Inc.
DePuy Synthes (Johnson & Johnson)
Stryker Corporation
Smith & Nephew plc
Corin Group PLC
Waldemar Link GmbH & Co. KG
MicroPort Scientific Corporation
Exactech, Inc.
Corentec Co., Ltd.
Enovis Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa